M H Witte,M J Bernas
M H Witte
Editorial
Lymphology. 2015 Dec;48(4):161-2. DOI: 2015
Professor Alfred Bollinger January 23, 1932-April 3, 2015 [0.03%]
阿尔弗雷德·博林格教授追思：1932年1月23日-2015年4月3日
Felix Mahler
Felix Mahler
K Leela Praveen Kumar,G Manokaran
K Leela Praveen Kumar
Genital lymphedema is a common problem seen by lymphology surgeons in India due to filarial infections. We have developed an innovative operative technique to correct this issue using native skin and have found the results in the first fift...
J Rothbauer,S Driver,L Callender
J Rothbauer
Turner syndrome (TS) is a chromosomal condition affecting an estimated 1 in 2,500 girls where the second X chromosome is missing, or partially formed. This abnormality affects multiple body systems and can lead to short stature, cardiac, ne...
Observational Study
Lymphology. 2015 Sep;48(3):139-52. DOI: 2015
VALIDATION OF THE LYMPHEDEMA LIFE IMPACT SCALE (LLIS): A CONDITION-SPECIFIC MEASUREMENT TOOL FOR PERSONS WITH LYMPHEDEMA [0.03%]
淋巴水肿生命影响量表（LLIS）的验证：一种用于淋巴水肿患者的疾病特异性测量工具
J Weiss,T Daniel
J Weiss
Evidence-based practice supports the use of validated outcome measures to assess the impact of lymphedema; however, condition-specific lymphedema assessment measures are needed. The Lymphedema Life Impact Scale (LLIS) was developed as a com...
Multicenter Study
Lymphology. 2015 Sep;48(3):128-38. DOI: 2015
LYMPHODYSPLASIA AND KRAS MUTATION: A CASE REPORT AND LITERATURE REVIEW [0.03%]
淋巴发育不良和KRAS突变：1例报道及文献复习
G Morcaldi,T Bellini,C Rossi et al.
G Morcaldi et al.
Cardio-facio-cutaneous (CFC) syndrome is a very rare and sporadic disease whose characteristics include dysmorphic facial appearance, ectodermal abnormalities, cardiac abnormalities, growth retardation and neurodevelopmental delay. This syn...
Review
Lymphology. 2015 Sep;48(3):121-7. DOI: 2015
DOES TREATMENT ALLEVIATE LYMPHEDEMA SYMPTOMS? A CROSS-SECTIONAL STUDY EVALUATING PATIENT PERSPECTIVES [0.03%]
治疗能缓解淋巴水肿症状吗？一项评估患者观点的横断面研究
A Finnane,M Janda,S C Hayes
A Finnane
Most studies evaluating lymphedema treatment effect focus on objective reductions in limb volume, with little attention given to subjective treatment outcomes. The objective of this work was to describe the range of lymphedema symptoms expe...
IN MEMORIAM. Sam A. Threefoot, MD, April 10, 1921- April 25, 2015 [0.03%]
悼念萨姆·A·特里斯福博士(1921年4月10日-2015年4月25日)
Barbara S Mattingly
Barbara S Mattingly
SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS [0.03%]
西罗莫司成功治疗淋巴管肌瘤病的肺和淋巴表现
A Hecimovic,M Jakopovic,G Pavlisa et al.
A Hecimovic et al.
Lymphangioleiomyomatosis (LAM) is a rare, progressive, diffuse cystic lung disease predominantly affecting women of child bearing age. Recently treatment with sirolimus was shown to stabilize lung function decline and improve quality of lif...
Clinical Trial
Lymphology. 2015 Jun;48(2):97-102. DOI: 2015
A NOVEL FLT4 GENE MUTATION AND MR LYMPHANGIOGRAPHY IN A CHINESE FAMILY WITH MILROY DISEASE [0.03%]
Milroy病一家系的FLT4基因新突变及MAL影像学表现
N F Liu,Z Yu,Y Luo et al.
N F Liu et al.
Milroy disease is a congenital onset lymphedema linked to FLT4 gene mutations in the tyrosine kinase domain. So far, a total of 59 different FLT4 variants have been identified. Here, we report a novel FLT4 gene mutation in a Chinese family ...
Case Reports
Lymphology. 2015 Jun;48(2):93-6. DOI: 2015